Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics Licenses Access to Harvard Health Information

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Consumer genetic testing and ancestry firm Pathway Genomics said today that it has licensed genetic disease information developed by Harvard Medical School through an agreement with StayWell Consumer Health Publishing.

The content covered under the agreement was developed by HMS and Harvard Health Publications. Pathway Genomics will use it to offer its Genetic Health Reports, which provide its customers with information about genetic diseases and medical information such as symptoms, diagnosis, duration, prevention, and treatment options.

"When customers review their Genetic Health Reports they want to easily access detailed information – from a trusted source – about health conditions reported with their genetic results," Pathway Genomics Chief Medical Officer Michael Nova said in a statement.

While genetic testing can tell if individuals have certain genetic markers, it does not offer certainty about whether someone will get a disease, Pathway Genomics Director of Clinical Genetics Linda Wasserman pointed out, saying that this "is where the role of genetic counseling comes into play." By offering access to the Harvard-developed information, "we can quickly refer our customers to a source of information that is current and accurate," she said.

Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.